After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Xilio Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Xilio Therapeutics Inc is $48.51M. A total of 0.56 million shares were traded on the day, compared to an average of 1.13M shares.
In the most recent transaction, Frankenfield Christopher James sold 6,954 shares of XLO for 0.98 per share on Jan 02 ’25. After the transaction, the Chief Financial Officer now owns 12,421 company shares. In a previous transaction on Jan 02 ’25, Brennan Kevin M. sold 1,803 shares at 0.98 per share. XLO shares that SVP, FINANCE AND ACCOUNTING owns now total 3,197.
Among the insiders who bought shares, GILEAD SCIENCES, INC. acquired of 1,759,978 shares on Dec 18 ’24 at a per-share price of $1.04. This resulted in the 10% Owner holding 9,105,451 shares of XLO after the transaction.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, XLO has a high of $1.70 and a low of $0.62.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. XLO’s latest balance sheet shows that the firm has $198.05M in Cash & Short Term Investments as of fiscal 2021. There were $20.54M in debt and $12.78M in liabilities at the time. Its Book Value Per Share was $0.21, while its Total Shareholder’s Equity was $185.43M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XLO is Buy with a score of 5.00.
